Search A-Z index Contact
University of Cambridge Home Dr Darerca Owen
University of Cambridge >  School of the Biological Sciences  >  Department of Biochemistry spacerStaff email list spacerPhone
Research Groups

 

 

 

Darerca Owen
Visit Owen-Mott group web site

G Proteins and their Effectors as Therapeutic Targets in Invasion and Metastasis

Research Grouping: Structural and molecular cell biology

For the majority of cancers the acquisition of invasive and metastatic characteristics leads to incurable disease in the host. A major challenge, therefore, is the elucidation of the underlying molecular changes that lead to the unimpeded ability of tumour cells to invade neighbouring tissue and disperse to secondary sites and the development of therapies to arrest such a progression. Small G proteins, particularly members of the Rho family, are known regulators of the actin cytoskeleton and therefore control the morphology and motility of mammalian cells. It is not surprising therefore, that they are implicated with increasing frequency in the transition to invasive and metastatic forms of cancers. This implies the existence of a therapeutic avenue directed against these proteins and their downstream effectors.

ACK hotspots on model of Cdc42

Our work addresses the relationship between structure and function in small G proteins and their effector complexes. We have determined the structures (by NMR) of the G protein, Cdc42, in complex with the G protein binding domains of its effector proteins ACK and PAK. ACK is known to function in integrin mediated adhesion pathways, while PAK is involved both in tumourigenicity and adhesion, being particularly identified as active in breast cancer metastasis. Our structures facilitated the design of mutations that selectively inhibited the interaction of Cdc42 with its effectors. Thermodynamic analysis of these mutants led to the identification of 'hotspots' on the G protein surface that define areas which could be targeted by small molecules for therapeutic purposes (figure 1). We have also studied the interaction of PRK1, another kinase with a potential role in invasion, with the Rho and Rac GTPases. We have solved the structure of the HR1b repeat of PRK1 and have used a combination of NMR and mutagenesis to determine the residues important for the interaction between Rac and PRK1 (figure 2).

HR1b stuctural models

Recently, we have also extended our investigations to include the Ras family member, Ral. Preliminary data indicate that the control of exocytosis by Ral is involved in cell motility and therefore another possible target for anti-metastasis therapies.
First and foremost we hope our work will lead to a more detailed understanding of the protein/protein interactions involved in cell motility. The data generated, however, could also provide regulatory, structural, thermodynamic and in some cases kinetic data to assist rational drug design

Lab members
Louise Campbell, Jose Vicente-Garcia, Catherine Hutchinson, Kadalmani Krishnan, Irina Ogay

References

  1. Mott, H.R., Owen, D., Nietlispach, D., Lowe, P.N., Manser, E., Lim, L. & Laue, E.D. (1999) Structure of the small G protein Cdc42 bound to the GTPase-binding domain of ACK Tyrosine Kinase. Nature 399, 384-388.
  2. Mott, H.R., Nietlispach, D. Hopkins, L., Mirey, G., Camonis, J. & Owen, D. (2003) Structure of the GTPase-Binding domain of Sec5 and Investigation of its Ral-binding Site. J.Biol.Chem. 278, 17053-17059.
  3. Owen, D., Lowe, P.N., Nietlispach, D., Brosnan, C.E., Chirgadze, D.Y., Parker, P.J., Blundell, T.L. & Mott, H.R. (2003) Molecular dissection of the interaction between the small G proteins Rac1 and RhoA and Protein Kinase C Related Kinase 1 (PRK1). J.Biol.Chem. 278, 50578-50587.

Valid XHTML 1.0!